Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – Should You Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) was up 3.8% during trading on Thursday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Up 3.8%

The business’s fifty day moving average is $2.14 and its two-hundred day moving average is $2.14. The stock has a market cap of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83.

Institutional Trading of Know Labs

Large investors have recently modified their holdings of the stock. Cerity Partners LLC acquired a new stake in shares of Know Labs in the second quarter valued at $158,000. Corient Private Wealth LLC acquired a new position in Know Labs during the 2nd quarter worth $99,000. Finally, Bard Financial Services Inc. acquired a new position in Know Labs during the 3rd quarter worth $80,000. Hedge funds and other institutional investors own 23.96% of the company’s stock.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.